Metabolic control by insulin detemir in basal‐bolus therapy: treat‐to‐target study in children and adolescents with type 1 diabetes

To assess the efficacy and safety of insulin detemir administered once vs. twice daily in children and adolescents with type 1 diabetes mellitus.

[1]  V. Peterkova,et al.  Treatment with insulin detemir or NPH insulin in children aged 2–5 yr with type 1 diabetes mellitus , 2011, Pediatric diabetes.

[2]  V. Basevi.  Standards of Medical Care in Diabetes—2011 , 2011, Diabetes Care.

[3]  S. Heller,et al.  Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: a 52-week, multinational, randomized, open-label, parallel-group, treat-to-target noninferiority trial. , 2009, Clinical therapeutics.

[4]  S. Kurtoğlu,et al.  Insulin detemir improves glycemic control and reduces hypoglycemia in children with type 1 diabetes: findings from the Turkish cohort of the PREDICTIVE™ observational study , 2009, Pediatric diabetes.

[5]  H. Gin,et al.  Effect of insulin detemir dose frequency on clinical outcomes in patients with diabetes in PREDICTIVE , 2009, Advances in therapy.

[6]  E. Eren,et al.  Comparison of the Efficacy and Safety of Insulin Glargine and Insulin Detemir with NPH Insulin in Children and Adolescents with Type 1 Diabetes Mellitus Receiving Intensive Insulin Therapy , 2009, Journal of clinical research in pediatric endocrinology.

[7]  J. Rosenbauer,et al.  Changes in the Use of Analogue Insulins in 37 206 Children and Adolescents with Type 1 Diabetes in 275 German and Austrian Centers during the Last Twelve Years , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[8]  O. Kordonouri,et al.  Insulin detemir is characterized by a more reproducible pharmacokinetic profile than insulin glargine in children and adolescents with type 1 diabetes: results from a randomized, double‐blind, controlled trial * , 2008, Pediatric diabetes.

[9]  M. Lévy,et al.  Comparison of Once- Versus Twice-Daily Administration of Insulin Detemir, Used With Mealtime Insulin Aspart, in Basal-Bolus Therapy for Type 1 Diabetes , 2008, Diabetes Care.

[10]  M. Lang-Muritano,et al.  Improved glycemic control and lower frequency of severe hypoglycemia with insulin detemir; long‐term experience in 105 children and adolescents with type 1 diabetes , 2008, Pediatric diabetes.

[11]  W. Młynarski,et al.  Insulin sensitivity in Type 1 diabetic children and adolescents , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[12]  Z. Gucev,et al.  Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[13]  S. Ashwell,et al.  Twice‐daily compared with once‐daily insulin glargine in people with Type 1 diabetes using meal‐time insulin aspart , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[14]  J. Plank,et al.  A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemir. , 2005, Diabetes care.

[15]  U. Ribel,et al.  The Mechanism of Protraction of Insulin Detemir, a Long-Acting, Acylated Analog of Human Insulin , 2004, Pharmaceutical Research.

[16]  L. Heinemann,et al.  Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes. , 2004, Diabetes.

[17]  T. Danne,et al.  Insulin detemir is characterized by a consistent pharmacokinetic profile across age-groups in children, adolescents, and adults with type 1 diabetes. , 2003, Diabetes care.

[18]  T. Jones,et al.  Hypoglycemia: Incidence and Clinical Predictors in a Large Population-Based Sample of Children and Adolescents with IDDM , 1997, Diabetes Care.

[19]  J M Tanner,et al.  Variations in the Pattern of Pubertal Changes in Boys , 1970, Archives of disease in childhood.

[20]  J M Tanner,et al.  Variations in pattern of pubertal changes in girls. , 1969, Archives of disease in childhood.

[21]  Y. Jang,et al.  Standards of Medical Care in Diabetes-2010 by the American Diabetes Association: Prevention and Management of Cardiovascular Disease , 2010 .

[22]  Clare Bradley,et al.  Handbook of Psychology and Diabetes : A Guide to Psychological Measurement in Diabetes Research and Practice , 1994 .